CA
MACK

Commerzbank Aktiengesellschaft’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,894
Closed -$123 – 1063
2016
Q2 		$123 Hold
2,894
– – ﹤0.01% 960
2016
Q1 		$191K Sell
2,894
-278
-9% -$14.5K ﹤0.01% 965
2015
Q4 		$197K Buy
3,172
+457
+17% +$32.2K ﹤0.01% 1068
2015
Q3 		$182K Sell
2,715
-2,017
-43% -$165K ﹤0.01% 1045
2015
Q2 		$460K Sell
4,732
-654
-12% -$62.2K ﹤0.01% 998
2015
Q1 		$503K Buy
5,386
+166
+3% +$14.1K ﹤0.01% 955
2014
Q4 		$464K Buy
+5,220
New +$380K ﹤0.01% 1019

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Commerzbank Aktiengesellschaft's MACK Position: Q3 2016 in Review

Commerzbank Aktiengesellschaft sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2016, closing a stake of 2,894 shares — an estimated $123 sold.

Commerzbank Aktiengesellschaft first reported a position in MACK in Q4 2014 and held it in 7 quarters. The position peaked at $503K in Q1 2015. 128 funds tracked by Wall St. Rank hold MACK as of Q3 2016.

  • Commerzbank Aktiengesellschaft reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 2,894 Merrimack Pharmaceuticals, Inc. shares in Q3 2016, an estimated $123.
  • Commerzbank Aktiengesellschaft first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2014 and held it in 7 quarters.
  • Commerzbank Aktiengesellschaft's Merrimack Pharmaceuticals, Inc. position peaked at $503K in Q1 2015.
  • 128 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2016, filed 14 Nov 2016.